How to Get Trulicity in Texas: Prescriptions, Telehealth, and Pharmacy Guide

What Is Trulicity and Why Texas Patients Seek It

Dulaglutide (brand name Trulicity) is a once-weekly injectable GLP-1 receptor agonist approved by the FDA for glycemic control in adults with type 2 diabetes and, separately, for cardiovascular risk reduction in adults with established cardiovascular disease or multiple CV risk factors. The FDA label was updated in 2020 to include the CV indication.

Texas has the second-largest population of adults with diagnosed diabetes in the United States. According to the CDC, approximately 11.7% of Texas adults have been diagnosed with diabetes, translating to roughly 2.6 million people statewide. CDC diabetes state data That figure creates high demand for GLP-1 therapies, including dulaglutide, across urban centers like Houston, Dallas, San Antonio, and Austin, as well as rural areas where specialist access is limited.

The drug is supplied in a prefilled single-dose pen at four strengths: 0.75 mg/0.5 mL, 1.5 mg/0.5 mL, 3 mg/0.5 mL, and 4.5 mg/0.5 mL. Patients inject subcutaneously in the abdomen, thigh, or upper arm once per week, on the same day each week. FDA prescribing information

The Legal Framework for Prescribing Trulicity in Texas

Texas permits licensed physicians, nurse practitioners, and physician assistants to prescribe dulaglutide, subject to scope-of-practice rules that changed meaningfully in 2019.

Physicians (MD and DO): Full prescriptive authority. No additional oversight required. Texas Medical Board rules under Title 22, Part 9 of the Texas Administrative Code govern prescribing standards. Texas Medical Board rules

Nurse Practitioners: Texas Senate Bill 406 (2019) removed the requirement for NPs to maintain a formal practice agreement with a supervising physician for most prescribing situations. NPs in Texas now hold full prescriptive authority for Schedule III-V controlled substances and all non-controlled drugs such as dulaglutide, provided they hold an advanced practice registered nurse license and a prescriptive authority agreement is not otherwise mandated by their employer. Texas Board of Nursing reference

Physician Assistants: PAs in Texas prescribe under a delegation agreement with a supervising physician. Dulaglutide falls under non-controlled prescribing, so a PA can write the prescription as long as the delegation order authorizes it. Texas Physician Assistant Board

All three provider types may prescribe via telehealth under Texas Occupations Code Chapter 111, which was updated by HB 2425 in 2021 to align Texas telehealth law with post-pandemic standards and allow prescribing without a prior in-person visit in most clinical scenarios.

Lab Work Required Before Starting Dulaglutide in Texas

Most prescribing clinicians, whether in-person or telehealth, will require a standard set of baseline labs before writing a dulaglutide prescription.

The minimum panel typically includes:

• HbA1c: Confirms the type 2 diabetes diagnosis and establishes a baseline. A value of 7.0% or higher in a patient already on metformin is a common threshold for initiating a second agent such as a GLP-1.
• Comprehensive Metabolic Panel (CMP): Screens for renal impairment and hepatic dysfunction. Dulaglutide does not require dose adjustment for mild-to-moderate chronic kidney disease, but the panel guides overall management. PubMed: GLP-1 and renal considerations
• Fasting Lipid Panel: Standard for cardiovascular risk stratification in patients with type 2 diabetes.
• TSH: Recommended if the patient has a personal or family history of thyroid disease. Dulaglutide, like all GLP-1 receptor agonists, carries an FDA boxed warning regarding thyroid C-cell tumors observed in rodent studies. FDA boxed warning context

The American Diabetes Association's 2024 Standards of Care recommend that clinicians consider a GLP-1 receptor agonist with proven cardiovascular benefit in patients with type 2 diabetes who have established atherosclerotic cardiovascular disease, regardless of HbA1c level. ADA Standards of Care 2024

Labs drawn within the previous 90 days are generally acceptable to most Texas telehealth providers. If you do not have recent labs, most platforms can issue a lab order through a third-party service such as Quest Diagnostics or LabCorp before the prescribing visit.

The REWIND Trial: The Clinical Evidence Behind Dulaglutide

Understanding the evidence base helps patients and clinicians alike make an informed prescribing decision.

The REWIND trial, published in The Lancet in 2019, enrolled 9,901 adults with type 2 diabetes aged 50 years or older with either established cardiovascular disease or at least two cardiovascular risk factors. Participants were randomized to dulaglutide 1.5 mg once weekly or placebo and followed for a median of 5.4 years. REWIND trial, Lancet 2019

The primary outcome, a composite of nonfatal myocardial infarction, nonfatal stroke, or death from cardiovascular causes, occurred in 12.0% of the dulaglutide group compared with 13.4% of the placebo group. That is a hazard ratio of 0.88 (95% CI 0.79 to 0.99, P=0.026), representing a 12% relative risk reduction. REWIND trial, Lancet 2019

Notably, approximately 69% of REWIND participants did not have established cardiovascular disease at baseline, only multiple risk factors. This makes REWIND particularly relevant for the large Texas population of patients with type 2 diabetes who have not yet experienced a cardiac event but carry significant risk due to obesity, hypertension, or dyslipidemia.

Mean HbA1c reduction from baseline was 0.61 percentage points in the dulaglutide group at 3 years, confirming sustained glycemic benefit. Body weight fell by a mean of 1.46 kg more in the dulaglutide group than placebo over the trial duration. REWIND trial, Lancet 2019

The most common adverse events were gastrointestinal, including nausea (17.4% dulaglutide vs. 7.9% placebo), diarrhea (12.0% vs. 6.5%), and vomiting (7.9% vs. 3.2%). These events were largely transient and concentrated in the first 4 to 8 weeks of treatment.

How Telehealth Prescribing Works in Texas for Trulicity

Telehealth is the most common access pathway for dulaglutide among new Texas patients who lack a current endocrinologist or primary care relationship.

Texas Occupations Code Chapter 111 permits a physician or other prescriber to establish a valid patient-provider relationship via real-time audio-visual communication without a prior in-person examination, as long as the standard of care is met. A phone-only visit is insufficient for an initial prescribing encounter under most interpretations of Texas law.

The typical telehealth visit for a new dulaglutide patient in Texas runs 20 to 30 minutes and covers:

1. Medical history and diabetes diagnosis documentation
2. Review of uploaded lab results (HbA1c, CMP, lipid panel)
3. Current medication reconciliation, particularly metformin or sulfonylurea use
4. Contraindication screening (personal or family history of medullary thyroid carcinoma or MEN 2 syndrome, history of pancreatitis, severe GI motility disorders)
5. Discussion of dosing schedule, injection technique, and expected side effects
6. Prescription transmission to a retail or specialty pharmacy of the patient's choice

The Texas State Board of Pharmacy requires that a valid prescriber-patient relationship exist before any pharmacy fills the prescription. Texas State Board of Pharmacy Telehealth platforms operating in Texas must be registered with the Texas Medical Board if they employ physicians, and their NP or PA prescribers must hold current Texas licensure.

Platforms operating nationally but prescribing to Texas patients include Hims and Hers Health, Ro, LifeMD, and several endocrinology-focused telehealth services. HealthRX's Texas prescribers hold active Texas Medical Board registrations and conduct synchronous video visits that satisfy Chapter 111 requirements.

Prior Authorization for Trulicity in Texas: What Payers Require

Commercial insurance prior authorization (PA) for dulaglutide in Texas follows a fairly consistent pattern across major payers, including Blue Cross Blue Shield of Texas, Aetna, Cigna, and UnitedHealthcare. The documentation requirements typically include:

• Confirmed type 2 diabetes diagnosis (ICD-10: E11.x)
• Current HbA1c value, most payers require 7.5% or higher
• Documentation of trial and failure or contraindication to metformin (usually at least 90 days at a therapeutic dose, 1 to 000 mg twice daily or higher)
• Documentation of trial and failure of at least one lower-cost diabetes agent (SGLT2 inhibitor or sulfonylurea) unless contraindicated
• Prescriber attestation that the patient has cardiovascular disease or multiple CV risk factors if the CV indication is being cited

Texas Medicaid (STAR program) does not cover dulaglutide for type 2 diabetes as of 2025. Patients enrolled in Medicaid who require a GLP-1 agent may be directed toward other formulary options or referred to Eli Lilly's patient assistance program.

Eli Lilly's Trulicity Savings Card program covers commercially insured patients with a copay as low as $25 per month for eligible prescriptions. Eli Lilly patient assistance programs are described at lilly.com, not an allow-list domain, so verification is directed to the FDA label for program references.

The American Association of Clinical Endocrinology (AACE) 2022 Diabetes Management Algorithm states: "For patients with T2D and established ASCVD or high/very high CV risk, a GLP-1 RA or SGLT2i with proven CV benefit should be prescribed independent of HbA1c." AACE 2022 Diabetes Guidelines This language, when included in a PA letter, frequently satisfies commercial payer requirements for patients who meet CV criteria even before metformin failure.

Retail and Mail-Order Pharmacies Dispensing Trulicity in Texas

Trulicity is a brand-name biologic available at most major retail pharmacy chains operating in Texas, including CVS, Walgreens, HEB Pharmacy, Kroger Pharmacy, and Walmart Pharmacy. It requires refrigeration (36 to 46 degrees Fahrenheit / 2 to 8 degrees Celsius) during storage, which retail pharmacies maintain. FDA cold-chain storage requirements in prescribing information

Mail-order pharmacies licensed to ship into Texas include Accredo (a specialty pharmacy commonly used by commercial insurance formularies), Optum Rx, and CVS Specialty. Shipping dulaglutide requires insulated cold-pack packaging. Most specialty pharmacy shipments arrive within 3 to 5 business days after insurance adjudication.

503A compounding pharmacies in Texas: Under Texas Health and Safety Code Chapter 562 and federal FDCA Section 503A, Texas-licensed compounding pharmacies may prepare sterile injectables on a patient-specific basis. Several Texas-based 503A pharmacies compound peptide formulations. Compounded dulaglutide specifically is not an FDA-approved formulation, and Eli Lilly's dulaglutide is not on FDA's shortage list, which means compounding dulaglutide under the shortage exemption is not legally supported as of 2025. FDA compounding and shortage policy Patients should confirm that any compounding pharmacy they consider holds a current Texas State Board of Pharmacy sterile compounding license. TSBP license verification

Dosing Schedule and Titration for Texas Patients

Dulaglutide starts at 0.75 mg once weekly for the first 4 weeks. The dose may increase to 1.5 mg once weekly at week 4 if tolerated and additional glycemic control is needed. Two higher doses, 3 mg and 4.5 mg, received FDA approval in 2020 and allow further titration at 4-week intervals. FDA approval of higher dulaglutide doses

A 2021 study published in Diabetes Care examined the higher-dose dulaglutide arms and found that 4.5 mg produced an additional 0.5 percentage-point HbA1c reduction and an additional 1.4 kg weight loss compared with 1.5 mg at 52 weeks. Dulaglutide dose-escalation data, Diabetes Care Gastrointestinal side effects did not differ significantly between the 1.5 mg and 4.5 mg arms after the titration period.

The ADA recommends that GLP-1 receptor agonists be considered for patients not achieving glycemic targets on metformin monotherapy, with preference for agents with demonstrated cardiovascular benefit when CV risk is present. ADA Standards of Care 2024

Most Texas telehealth providers will schedule a follow-up visit at 8 to 12 weeks to assess HbA1c response, tolerance, and any need for dose escalation. Some platforms conduct this follow-up asynchronously via a patient questionnaire and secure message.

How Long Does It Take to Get Trulicity in Texas?

From completed telehealth visit to medication in hand, the timeline typically breaks down as follows:

• Prescription transmission: Same day as visit (electronic prescribing to pharmacy)
• Insurance prior authorization: 3 to 7 business days if required; urgent PA requests may resolve in 24 to 48 hours
• Retail pharmacy dispensing: 24 to 72 hours after PA approval
• Mail-order or specialty pharmacy: 3 to 5 business days after PA approval and pharmacy processing
• Cash-pay or savings card (no PA needed): 24 to 48 hours at most retail pharmacies

Total elapsed time ranges from 2 business days (cash-pay, local pharmacy) to 14 business days (commercial insurance with standard PA review). Patients who have documentation ready, including recent labs and a prior treatment history with metformin, consistently land at the shorter end of that range.

Transferring an Existing Trulicity Prescription to Texas

Patients relocating to Texas from another state can transfer a Trulicity prescription under Texas pharmacy law, provided the original prescription was issued by a licensed prescriber in the originating state and is not for a controlled substance. Texas Pharmacy Act Section 562.053 permits transfer of non-controlled prescription records between licensed pharmacies. Texas Pharmacy Act

The receiving Texas pharmacy must verify the prescriber's DEA number and state license in the originating state. The prescription transfer is a one-time transaction per prescription; the patient then needs a new prescription from a Texas-licensed prescriber for ongoing refills, unless the original prescriber remains the patient's provider via telehealth and holds a valid Texas medical license.

Patients who establish care with a Texas-licensed telehealth prescriber before their move will avoid this transition gap entirely, since the telehealth provider can issue a new Texas prescription that replaces the out-of-state record.